Rachel Denholm1, Richard Morris2, Rupert Payne2. 1. Centre for Academic Primary Care, Bristol Medical School, University of Bristol, Bristol, UK. r.denholm@bristol.ac.uk. 2. Centre for Academic Primary Care, Bristol Medical School, University of Bristol, Bristol, UK.
Abstract
PURPOSE: To describe prescribing of medicines in primary care in the last year of life in patients with dementia. METHOD: A retrospective cohort analysis in UK primary care using routinely collected data from the Clinical Practice Research Datalink. Number of medications and potentially inappropriate medication prescribed one year prior to, and including death, was ascertained. RESULTS: Dementia patients (n = 6923) aged 86.6 ± 7.3 years (mean ± SD) were prescribed 4.8 ± 4.0 drugs 1 year prior to death, increasing to 5.6 ± 4.0 2 months prior, before falling to 4.9 ± 4.1 at death. One year prior to death, 50% of patients were prescribed a potentially inappropriate medication, falling to 41% at death. Cardiovascular medications were the most common, with decreases in drug count only occurring in the last month prior to death. Prescriptions for gastrointestinal and central nervous system medication increased throughout the year, particularly laxatives/analgaesics, antidepressants and hypnotic/antipsychotics. Women (vs. men) and patients with Alzheimer's (vs. vascular dementia) were prescribed 4.7% (95% CI 2.3%-7%) and 14.6% (11.7-17.3%) fewer medications, respectively. Prescribing decreased with age and increased with additional comorbidities. CONCLUSIONS: Dementia patients are prescribed high levels of medication, many potentially inappropriate, during their last year of life, with reductions occurring relatively late. Improvements to medication optimisation guidelines are needed to inform decision-making around deprescribing of long-term medications in patients with limited life-expectancy.
PURPOSE: To describe prescribing of medicines in primary care in the last year of life in patients with dementia. METHOD: A retrospective cohort analysis in UK primary care using routinely collected data from the Clinical Practice Research Datalink. Number of medications and potentially inappropriate medication prescribed one year prior to, and including death, was ascertained. RESULTS:Dementiapatients (n = 6923) aged 86.6 ± 7.3 years (mean ± SD) were prescribed 4.8 ± 4.0 drugs 1 year prior to death, increasing to 5.6 ± 4.0 2 months prior, before falling to 4.9 ± 4.1 at death. One year prior to death, 50% of patients were prescribed a potentially inappropriate medication, falling to 41% at death. Cardiovascular medications were the most common, with decreases in drug count only occurring in the last month prior to death. Prescriptions for gastrointestinal and central nervous system medication increased throughout the year, particularly laxatives/analgaesics, antidepressants and hypnotic/antipsychotics. Women (vs. men) and patients with Alzheimer's (vs. vascular dementia) were prescribed 4.7% (95% CI 2.3%-7%) and 14.6% (11.7-17.3%) fewer medications, respectively. Prescribing decreased with age and increased with additional comorbidities. CONCLUSIONS:Dementiapatients are prescribed high levels of medication, many potentially inappropriate, during their last year of life, with reductions occurring relatively late. Improvements to medication optimisation guidelines are needed to inform decision-making around deprescribing of long-term medications in patients with limited life-expectancy.
Authors: Jennifer Tjia; Margaret R Rothman; Dan K Kiely; Michele L Shaffer; Holly M Holmes; Greg A Sachs; Susan L Mitchell Journal: J Am Geriatr Soc Date: 2010-04-14 Impact factor: 5.562
Authors: Holly M Holmes; Greg A Sachs; Joseph W Shega; Gavin W Hougham; Deon Cox Hayley; William Dale Journal: J Am Geriatr Soc Date: 2008-05-12 Impact factor: 5.562
Authors: David M Blass; Betty S Black; Hilary Phillips; Thomas Finucane; Alva Baker; David Loreck; Peter V Rabins Journal: Int J Geriatr Psychiatry Date: 2008-05 Impact factor: 3.485
Authors: Giuseppe Colloca; Matteo Tosato; Davide L Vetrano; Eva Topinkova; Daniela Fialova; Jacob Gindin; Henriëtte G van der Roest; Francesco Landi; Rosa Liperoti; Roberto Bernabei; Graziano Onder Journal: PLoS One Date: 2012-10-03 Impact factor: 3.240
Authors: Miriam Ryvicker; Yolanda Barrón; Shivani Shah; Stanley M Moore; James M Noble; Kathryn H Bowles; Jacqueline Merrill Journal: J Appl Gerontol Date: 2021-03-20
Authors: Samuel X Tan; Sarah C Cameron; Lit Min Sam; Hugh Eigeland; Karen Hay; Eamonn Eeles; Kannan Natarajan Journal: Aging Med (Milton) Date: 2021-08-27
Authors: Karlijn J Joling; Maud Ten Koppel; Hein P J van Hout; Bregje D Onwuteaka-Philipsen; Anneke L Francke; Robert A Verheij; Jos W R Twisk; Rob J van Marum Journal: Int J Geriatr Psychiatry Date: 2020-10-16 Impact factor: 3.485